France · Delayed Price · Currency is EUR Octopus Biosafety Statistics
Total Valuation
EPA:MLOCT has a market cap or net worth of EUR 23.90 million. The enterprise value is 24.42 million.
| Market Cap | 23.90M |
| Enterprise Value | 24.42M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
EPA:MLOCT has 127.13 million shares outstanding. The number of shares has increased by 269.15% in one year.
| Current Share Class | 127.13M |
| Shares Outstanding | 127.13M |
| Shares Change (YoY) | +269.15% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 62.06 |
| PB Ratio | -36.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -37.06 |
| EV / Sales | 63.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.32
| Current Ratio | 0.32 |
| Quick Ratio | 0.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -684.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -83.06% |
| Return on Invested Capital (ROIC) | -423.18% |
| Return on Capital Employed (ROCE) | 170.42% |
| Revenue Per Employee | 64,186 |
| Profits Per Employee | -109,851 |
| Employee Count | 6 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 20.57 |
Taxes
| Income Tax | -209,065 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.05% in the last 52 weeks. The beta is 0.18, so EPA:MLOCT's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +16.05% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 35.52 |
| Average Volume (20 Days) | 8,041 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:MLOCT had revenue of EUR 385,114 and -659,106 in losses. Loss per share was -0.04.
| Revenue | 385,114 |
| Gross Profit | -336,293 |
| Operating Income | -837,481 |
| Pretax Income | -868,171 |
| Net Income | -659,106 |
| EBITDA | -154,741 |
| EBIT | -837,481 |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 22,872 in cash and 546,838 in debt, giving a net cash position of -523,966 or -0.00 per share.
| Cash & Cash Equivalents | 22,872 |
| Total Debt | 546,838 |
| Net Cash | -523,966 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -655,967 |
| Book Value Per Share | -0.04 |
| Working Capital | -670,927 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -87.32%, with operating and profit margins of -217.46% and -171.15%.
| Gross Margin | -87.32% |
| Operating Margin | -217.46% |
| Pretax Margin | -225.43% |
| Profit Margin | -171.15% |
| EBITDA Margin | -40.18% |
| EBIT Margin | -217.46% |
| FCF Margin | n/a |
Dividends & Yields
EPA:MLOCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -269.15% |
| Shareholder Yield | -269.15% |
| Earnings Yield | -2.76% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EPA:MLOCT has an Altman Z-Score of -29.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -29.35 |
| Piotroski F-Score | 2 |